Diabetes mellitus comorbidity in patients enrolled in tuberculosis drug efficacy trials around the world: A systematic review.

Nurul Cholifah LutfianaJob Frank Martien van BovenMuhammad Asim Masoom ZubairMichelle J PenaJan Willem C Alffenaar

Published in: British journal of clinical pharmacology (2019)

Fewer than 1/3 recent TB drug trials reported the inclusion of DM. To better reflect real-world DM prevalence and differential TB drug effectiveness, inclusion of DM patients requires increased attention for future TB drug trials.

Keyphrases

end stage renal disease
mycobacterium tuberculosis
ejection fraction
chronic kidney disease
newly diagnosed
randomized controlled trial
systematic review
prognostic factors
emergency department
adverse drug
working memory
patient reported outcomes
hiv aids
pulmonary tuberculosis
hiv infected